Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000598220 | SCV000706013 | uncertain significance | not provided | 2017-02-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000817532 | SCV000958098 | likely benign | Familial aplasia of the vermis; Meckel-Gruber syndrome | 2024-01-08 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000598220 | SCV001772122 | uncertain significance | not provided | 2023-03-27 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant does not alter protein structure/function |
Fulgent Genetics, |
RCV002476313 | SCV002789732 | uncertain significance | Joubert syndrome 7; Meckel syndrome, type 5; COACH syndrome 3 | 2022-04-21 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001271341 | SCV001452426 | uncertain significance | Familial aplasia of the vermis | 2019-11-11 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004530699 | SCV004743786 | likely benign | RPGRIP1L-related disorder | 2022-03-14 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |